Gilead Sciences (Nasdaq: GILD), a Foster Metropolis, CA-based biopharmaceutical firm, acquired CymaBay Therapeutics, Inc. (Nasdaq: CBAY), CymaBay Therapeutics,…
Sign in to your account
Username or Email Address
Password
Remember Me